https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-cancer-drug/84614124
Zydus Cadila gets tentative nod from USFDA to market cancer drug, ETHealthworld
The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of 140...
zydus cadila
https://hr.economictimes.indiatimes.com/tag/zydus+cadila+healthcare+limited
Zydus cadila healthcare limited - Latest zydus cadila healthcare limited , Information & Updates -...
ETHRWorld.com brings latest zydus cadila healthcare limited news, views and updates from all top sources for the Indian HR industry.
zydus cadilalatest informationhealthcarelimitedupdates
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-manufacturing-doxycycline-injection-at-vadodara/76996737
Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at Vadodara, ETHealthworld
Doxycycline Injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections.
zydus cadilafor manufacturing
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-anti-cancer-drug/78291575
Zydus Cadila gets tentative USFDA nod to market anti-cancer drug, ETHealthworld
Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules.
zydus cadila
https://health.economictimes.indiatimes.com/tag/zydus+cadila+moraiya
Zydus cadila moraiya - Latest zydus cadila moraiya , Information & Updates - Health -ET HealthWorld
ETHealthworld.com brings latest zydus cadila moraiya news, views and updates from all top sources for the Indian Health industry.
zydus cadilalatest informationmoraiyaupdateshealth
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-diabetes-drug/78928067
Zydus Cadila gets tentative nod from USFDA to market diabetes drug, ETHealthworld
Zydus Cadila: The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
zydus cadila
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-antidepressant-drug/81210183
Zydus Cadila | USFDA: Zydus Cadila gets USFDA nod for antidepressant drug, ETHealthworld
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in...
zydus cadilausfdagetsnodantidepressant
https://adisinsight.springer.com/drugs/800055423?error=cookies_not_supported&code=eea18929-35e1-4d63-90ce-47c5174c60cd
Pertuzumab biosimilar - Zydus Cadila - AdisInsight
ZRC 3277 is a biosimilar version of pertuzumab [see AdisInsight drug profile 800014629], being developed by Zydus Cadila, for the treatment of breast cancer,
zydus cadilapertuzumabbiosimilaradisinsight
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-seeks-dcgi-approval-for-its-oral-pill-to-treat-anemia-due-to-ckd/87869471
Kidney Diseases: Zydus Cadila seeks DCGI approval for its oral pill to treat anemia due to CKD,...
Kidney Diseases: Zydus Cadila is seeking approval for Desidustat an oral pill alternative for the treatment of anemia due to Chronic Kidney Disease (CKD) in...
https://health.economictimes.indiatimes.com/news/pharma/cadila-arm-completes-sale-of-animal-health-business-for-rs-2921-crore/84439792
Zydus Animal Health And Investment: Cadila arm completes sale of animal health business for Rs...
In May this year, Zydus Animal Health and Investment has entered into definitive pacts for sale of its animal healthcare established markets undertaking to...
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-american-health-regulators-approval-to-market-mineral-supplement/78183277
Zydus Cadila gets American health regulator's approval to market mineral supplement, ETHealthworld
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the...
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-generic-prostate-cancer-drug-at-nearly-70-less-price-in-india/75639941
Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India, ETHealthworld
"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these unmet gaps comes...
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-lung-cancer-treatment-drug/83201464
Us Food And Drug Administration: Zydus Cadila gets tentative USFDA nod to market lung cancer...
The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg,...
food and drug administration
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/80446372
Covid Vaccine: Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug...
Covid Vaccine: In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate...
https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-indias-cheapest-remdesivir-version-at-rs-2800-per-100-mg-vial/77520875
Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vial, ETHealthworld
Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd....
https://www.business-standard.com/article/companies/zydus-cadila-gets-usfda-nod-to-market-mineral-supplement-tablets-120091800444_1.html
Zydus Cadila gets USFDA nod to market mineral supplement tablets | Company News - Business Standard
Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement used to treat or prevent low...
https://health.economictimes.indiatimes.com/news/pharma/usfda-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/80506195
Zydus Group: USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg, ETHealthworld
Zydus Group: Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax...
orphan drug designation
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/efforts-being-ramped-up-for-massive-production-of-vaccines-make-them-available-quickly-dbt-secretary/articleshow/82182341.cms
Zydus Cadila: Efforts being ramped up for massive production of vaccines, make them available...
Department of Biotechnology Secretary Renu Swarup said a financial support of Rs 400 crore is being provided to vaccine candidates from Zydus Cadilla,...